Purdue Pharma Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Purdue Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11233
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Purdue Pharma Inc (Purdue Pharma Canada), a subsidiary of Purdue Pharma LP is a research-based pharmaceutical company that offers services such as development, manufacturing and commercialization of medicines for patients and healthcare professionals. The company portfolio of products includes antiseptics, laxatives, decongestant, and prescription drugs, among others. It also provides medicines for pain, urinary incontinence, attention deficit hyperactivity disorder, respiratory disease, neurology, infection control, gastrointestinal disorders, psychiatry and others. Purdue Pharma conducts research for the discovery of new drugs, quality and clinical trials. The company works in partnership with other Purdue and Mundi companies globally for the development of new medicines. Purdue Pharma is headquartered in Pickering, Ontario, Canada.

Purdue Pharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Purdue Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 10
Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 11
Purdue Pharma Canada Enters into Licensing Agreement with Helsinn Group 12
Purdue Pharma Enters Into Licensing Agreement With Medical Developments 13
Helsinn Signs Licensing Agreement with Purdue Pharma Canada 14
Purdue Pharma Inc – Key Competitors 15
Purdue Pharma Inc – Key Employees 16
Purdue Pharma Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Sep 25, 2017: David A. Pidduck Appointed President and CEO of Purdue Pharma (Canada) 18
Jul 05, 2017: Purdue Pharma appoints Dr. Tom Koutsavlis as new Vice President, Research and Development 19
May 30, 2017: Purdue Pharma appoints Carina Vassilieva as new Vice President, Human Resources 20
Product News 21
Sep 04, 2018: BETADINE – A new treatment option for canadians for oral infections – now available in Canada 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Purdue Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Purdue Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 10
Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 11
Purdue Pharma Canada Enters into Licensing Agreement with Helsinn Group 12
Purdue Pharma Enters Into Licensing Agreement With Medical Developments 13
Helsinn Signs Licensing Agreement with Purdue Pharma Canada 14
Purdue Pharma Inc, Key Competitors 15
Purdue Pharma Inc, Key Employees 16

List of Figures
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Purdue Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Purdue Pharma Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HedgePath Pharmaceuticals Inc (HPPI):製薬・医療:M&Aディール及び事業提携情報
    Summary Hedgepath Pharmaceuticals Inc (Hedgepath), a subsidiary of Mayne Pharma Group Ltd, is a clinical stage biopharmaceutical company that discovers, develops and commercializes novel therapeutics for the treatment of skin, prostrate, and lung cancers. The company is investigating an oral formula …
  • Sacgasco Ltd (SGC):石油・ガス:M&Aディール及び事業提携情報
    Summary Sacgasco Ltd (Sacgasco), formerly Australian Oil Company Ltd is an energy company that offers conventional oil and gas exploration, development and production across Australia. The company develops and produces clean natural gas in the Sacramento Basin, onshore California. It explores Sacram …
  • Jadranka dd:企業の戦略・SWOT・財務分析
    Jadranka dd - Strategy, SWOT and Corporate Finance Report Summary Jadranka dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Dole Food Company Inc:企業のM&A・事業提携・投資動向
    Dole Food Company Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dole Food Company Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Xinjiang Goldwind Science & Technology Co Ltd (002202):企業の財務・戦略的SWOT分析
    Xinjiang Goldwind Science & Technology Co Ltd (002202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • Blue Coat Systems, Inc.:企業のM&A・事業提携・投資動向
    Blue Coat Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Blue Coat Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • BDO International Limited:企業の戦略・SWOT・財務情報
    BDO International Limited - Strategy, SWOT and Corporate Finance Report Summary BDO International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ribomic Inc (4591):製薬・医療:M&Aディール及び事業提携情報
    Summary Ribomic Inc (Ribomic), a subsidiary of Otsuka Pharmaceutical Co Ltd, is a biopharmaceutical venture company. The company develops molecular targeted pharmaceutical drugs using RNA aptamers. Its technology includes RiboART system a platform technology to treat therapeutic aptamers. Ribomic’s …
  • Genomic Expression Inc:企業の製品パイプライン分析
    Summary Genomic Expression Inc (Genomic Expression) is a provider of cancer diagnostics services that offers treatments for cancer diagnostics for personalized medicine. The company offers products such as sample sequencing sample preparation kit and analytical platform. Its sequencing platform prov …
  • Gulfport Energy Corp (GPOR):企業の財務・戦略的SWOT分析
    Gulfport Energy Corp (GPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Ecolab Inc (ECL):石油・ガス:M&Aディール及び事業提携情報
    Summary Ecolab Inc (Ecolab) provides water, hygiene and energy technologies and services. It offers solutions and services such as cleaning and sanitizing programs and products, pest elimination services, and equipment maintenance and repair services. The company caters to foodservice, food and beve …
  • Century Aluminum Co:企業の戦略・SWOT・財務情報
    Century Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Century Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • TUV Rheinland AG:企業の戦略的SWOT分析
    TUV Rheinland AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Jumboking Foods Pvt. Ltd.:企業の戦略・SWOT・財務分析
    Jumboking Foods Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Jumboking Foods Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Pakistan Water and Power Development Authority:電力:M&Aディール及び事業提携情報
    Summary Pakistan Water and Power Development Authority (WAPDA) is a government-owned public authority maintaining power and water in Pakistan. It is responsible for the development of hydel power and water sector projects in Pakistan. The authority plans and executes projects and schemes for the gen …
  • GDI Integrated Facility Services Inc (GDI):企業の財務・戦略的SWOT分析
    Summary GDI Integrated Facility Services Inc (GDI), formery Medwell Capital Corp is a commercial facility service provider. The company’s services include cleaning, food plant sanitation, technical trade services and energy management, healthcare sanitation, hotel support, event support and disaster …
  • Determine Inc (DTRM):企業の財務・戦略的SWOT分析
    Summary Determine Inc (Determine), formerly Selectica Inc and a subsidiary of Corcentric, is a technology company. The company provides SaaS source-to-pay and enterprise contract lifecycle management solutions. It offers solutions such as strategic sourcing, supplier management; procure to pay, invo …
  • Boule Diagnostics AB (BOUL)-医療機器分野:企業M&A・提携分析
    Summary Boule Diagnostics AB (Boule) is a medical device company that develops, manufactures and markets blood counting systems. The company provides systems and consumer products for complete blood counts to non-institutional healthcare. Its products include blood cell counter and instruments, reag …
  • BTG Plc (BTG):医療機器:M&Aディール及び事業提携情報
    Summary BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for …
  • China Grand Pharmaceutical and Healthcare Holdings Ltd (512)-医療機器分野:企業M&A・提携分析
    Summary China Grand Pharmaceutical and Healthcare Holdings Ltd (China Grand) is an investment holding company that develops, manufacture and distributes pharmaceutical preparations, medical devices and pharmaceutical intermediates, specialized raw materials, and healthcare products. The company’s pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆